Data as of Q4 2025 (Dec 31, 2025)

Veery Capital, LLC

โ€ขCIK: 1844375โ€ขFiling: Q4 2025

**Veery Capital, LLC** manages $326M across a diversified portfolio of 94 positions. The fund exhibits a significant allocation to U.S. large-cap growth and value indices, highlighted by top holdings in SCHG ($43.0M) and SCHV ($33.6M). Further concentration is visible in sector-specific and broad market ETFs, including IDEV ($32.5M) and VUG ($27.6M). The strategy maintains notable diversification across fixed income (BND at $20.3M) and international equities.

Total AUM
$325.8M
QoQ Performance
+2.9%
Positions
74
Top 10 Concentration
72.3%
Latest Filing
Q4 2025

Top Holdings Allocation

SCHG
SCHV
IDEV
VUG
VTV
BND
SCHG13.2%
SCHV10.3%
IDEV10.0%
VUG8.5%
VTV7.9%
BND6.2%
IEMG4.8%
IEFA4.0%

๐Ÿ“ˆ Biggest Buys

IDEV
ISHARES TR
+1.4%
10.0% of portfolio
VTV
VANGUARD INDEX FDS
+1.6%
7.9% of portfolio
BND
VANGUARD BD INDEX FDS
+1.9%
6.2% of portfolio
MUB
ISHARES TR
+3.2%
3.7% of portfolio
DKNG
DRAFTKINGS INC NEW
+21.4%
0.5% of portfolio

๐Ÿ“‰ Biggest Sells

SCHG
SCHWAB STRATEGIC TR
-1.1%
13.2% of portfolio
MSFT
MICROSOFT CORP
-3.5%
0.7% of portfolio
AMD
ADVANCED MICRO DEVICES INC
-11.6%
0.2% of portfolio
SCHO
SCHWAB STRATEGIC TR
-4.6%
0.4% of portfolio
HYD
VANECK ETF TRUST
-0.6%
1.7% of portfolio

Sector Breakdown

Other90.9%
Technology4.5%
Consumer1.4%
Financial1.2%
ETF0.9%
Healthcare0.6%
Energy0.3%
Industrial0.1%

๐Ÿšช Exited Positionssold since Q3 2025

ORCL
ORACLE CORP
SOLD
$304.0K
T
AT&T INC
SOLD
$298.1K
SAP
SAP SE
SOLD
$206.0K
BAC
VERIZON COMMUNICATIONS INC
SOLD
$203.7K
XERS
XERIS BIOPHARMA HOLDINGS INC
SOLD
$115.3K

Changes from Q3 2025

NEW5 new positions
โ†‘47 increased
โ†“22 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023